Becton Dickinson PE Ratio 2006-2019 | BDX

Current and historical p/e ratio for Becton Dickinson (BDX) from 2006 to 2019. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Becton Dickinson PE ratio as of October 18, 2019 is 22.73.
Becton Dickinson PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2019-10-18 258.59 90.73
2019-06-30 252.01 $2.85 88.42
2019-03-31 249.73 $3.37 74.10
2018-12-31 225.32 $3.25 69.33
2018-09-30 260.15 $0.44 591.24
2018-06-30 238.08 $2.32 102.62
2018-03-31 214.66 $-0.46 0.00
2017-12-31 211.33 $1.31 161.32
2017-09-30 192.79 $4.65 41.46
2017-06-30 191.26 $3.50 54.65
2017-03-31 179.15 $6.05 29.61
2016-12-31 161.04 $6.03 26.71
2016-09-30 174.05 $4.51 38.59
2016-06-30 163.63 $5.26 31.11
2016-03-31 145.91 $3.75 38.91
2015-12-31 147.43 $3.27 45.09
2015-09-30 126.39 $3.41 37.06
2015-06-30 134.35 $4.10 32.77
2015-03-31 135.61 $5.46 24.84
2014-12-31 130.89 $5.83 22.45
2014-09-30 106.59 $6.00 17.76
2014-06-30 110.27 $4.93 22.37
2014-03-31 108.64 $4.80 22.63
2013-12-31 102.04 $4.74 21.53
2013-09-30 91.91 $6.50 14.14
2013-06-30 90.36 $7.47 12.10
2013-03-31 86.97 $7.54 11.54
2012-12-31 70.73 $7.54 9.38
2012-09-30 70.61 $5.62 12.56
2012-06-30 66.79 $5.55 12.03
2012-03-31 68.96 $5.49 12.56
2011-12-31 65.96 $5.48 12.04
2011-09-30 64.33 $5.63 11.43
2011-06-30 75.22 $5.95 12.64
2011-03-31 69.17 $5.71 12.11
2010-12-31 73.05 $5.57 13.11
2010-09-30 63.72 $5.51 11.56
2010-06-30 57.84 $5.12 11.30
2010-03-31 66.99 $5.22 12.83
2009-12-31 66.78 $5.04 13.25
2009-09-30 58.79 $5.00 11.76
2009-06-30 59.82 $4.83 12.39
2009-03-31 56.13 $4.62 12.15
2008-12-31 56.80 $4.65 12.21
2008-09-30 66.31 $4.46 14.87
2008-06-30 66.95 $4.33 15.46
2008-03-31 70.45 $4.11 17.14
2007-12-31 68.37 $3.97 17.22
2007-09-30 66.89 $3.46 19.33
2007-06-30 60.54 $3.15 19.22
2007-03-31 62.28 $3.00 20.76
2006-12-31 56.63 $2.65 21.37
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $69.324B $15.983B
Becton, Dickinson & Company is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and health care worker safety and the technologies that enable medical research and clinical laboratories. The company provides innovative solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures, and support the management of diabetes. The company partners with organizations around the world to address some of the most challenging global health issues.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $27.830B 10.75
AmerisourceBergen (ABC) United States $18.811B 12.93
Align Technology (ALGN) United States $17.086B 46.61
Laboratory Of America Holdings (LH) United States $16.658B 15.77
Cardinal Health (CAH) United States $14.974B 9.70
Cooper (COO) United States $14.488B 24.52
Straumann Holding AG (SAUHF) Switzerland $13.854B 0.00
DENTSPLY SIRONA (XRAY) United States $12.319B 26.04
West Pharmaceutical Services (WST) United States $10.444B 45.39
Henry Schein (HSIC) United States $9.422B 16.77
CONMED (CNMD) United States $2.749B 41.89
Merit Medical Systems (MMSI) United States $1.672B 17.42
Patterson (PDCO) United States $1.670B 12.40
Atrion (ATRI) United States $1.484B 41.28
STAAR Surgical (STAA) United States $1.228B 72.58
Antares Pharma (ATRS) United States $0.564B 0.00
Invacare (IVC) United States $0.225B 0.00
Lifevantage (LFVN) United States $0.203B 24.39
Endologix (ELGX) United States $0.064B 0.00
Milestone Scientific (MLSS) United States $0.057B 0.00
Pro-Dex (PDEX) United States $0.055B 17.52
Retractable Technologies (RVP) United States $0.036B 0.00
Biolase (BIOL) United States $0.022B 0.00